Sign Out
Systemic administration of acyclovir did not produce embryotoxic or teratogenic effects in rabbits or rats.
Experience in humans is limited, so the use of acyclovir should be considered only when the potential benefits outweigh the possibility of unknown risks. Limited human data show that Medovir does pass into breast milk.
